Ameriprise Financial Q2 2025 Results: Net Income Surges 28%, Diluted EPS Rises 34%, Net Revenues Up 4%

Reuters
07-24
Ameriprise Financial <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Results: Net Income Surges 28%, Diluted EPS Rises 34%, Net Revenues Up 4%

Ameriprise Financial Inc. has reported its second-quarter 2025 financial results, showcasing a solid performance amidst market volatility. The company achieved a 4% increase in net revenues, reaching $4.375 billion compared to $4.220 billion in the same quarter of the previous year. Net income rose significantly by 28% to $1.060 billion, up from $829 million in Q2 2024. Earnings per diluted share $(EPS)$ increased by 34% to $10.73, compared to $8.02 in the prior-year period. Adjusted operating earnings per diluted share experienced a 7% rise to $9.11, maintaining a strong margin of 27%. In terms of capital management, Ameriprise returned $731 million to shareholders in the quarter and $3.0 billion over the last 12 months. The company also announced plans to accelerate share repurchase in the second half of 2025 to an 85% payout ratio, driven by share price and free cash flow generation. Despite a reduction in interest revenue due to a 100 basis point decrease in the federal funds effective rate in late 2024, equity markets showed recovery, ending the quarter 10% higher, which is expected to benefit the third-quarter results for Advice & Wealth Management and Asset Management.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ameriprise Financial Inc. published the original content used to generate this news brief on July 24, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10